Medicare Enrolled

Dr. Indranil Kushare

Pediatric Orthopaedic Surgery Physician · Conroe, TX
Speaking/Promotional
17580 INTERSTATE 45 S, Conroe, TX 77384
9362677200
In practice since 2013 (12 years)
NPI: 1609297894 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kushare from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kushare? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kushare

Dr. Indranil Kushare is a pediatric orthopaedic surgery physician in Conroe, TX, with 12 years in practice.

Between the years covered by Open Payments, Dr. Kushare received a total of $3,995 from 5 pharmaceutical and/or device companies across 13 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric orthopaedic surgery physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kushare is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice$ $3,995 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,995
Total received (2018-2024)
Avg $999/year across 4 years
Top 49% in TX for pediatric orthopaedic surgery physician
5
Companies
13
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,335 (58.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,660 (41.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,197
2023
$172
2020
$1,042
2018
$1,585

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medinc of Texas
$3,441
Stryker Corporation
$430
Arthrex, Inc.
$72
DePuy Synthes Sales Inc.
$38
Pacira Pharmaceuticals Incorporated
$14
Top 3 companies account for 98.7% of total payments
Associated products mentioned in payments ›
Exparel · MAKO · SALVATION · TRAUMA · TRITANIUM · VA-LCP PLATES & SCREWS
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric orthopaedic surgery physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for a pediatric orthopaedic surgery physician in Conroe?
Compare pediatric orthopaedic surgery physicians in the Conroe area by procedure volume, costs, and industry payment transparency.
Browse pediatric orthopaedic surgery physicians nearby

Geographic Context

Pediatric Orthopaedic Surgery Physicians within 10 mi
3
Per 100K population
0.5
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kushare is a pediatric orthopaedic surgery physician, and speaking/promotional industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Kushare receive payments from pharmaceutical companies?
Yes. Dr. Kushare received a total of $3,995 from 5 companies across 13 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kushare) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →